Ji Quanbo, Xu Xiaojie, Xu Yameng, Fan Zhongyi, Kang Lei, Li Ling, Liang Yingchun, Guo Jing, Hong Tian, Li Zhongli, Zhang Qiang, Ye Qinong, Wang Yan
Department of Orthopaedics, General Hospital of Chinese People's Liberation Army, Beijing, 100853, China.
Department of Medical Molecular Biology, Beijing Institute of Biotechnology, Beijing, 100850, China.
J Mol Med (Berl). 2016 Jun;94(6):681-94. doi: 10.1007/s00109-016-1380-9. Epub 2016 Jan 27.
Fibroblast growth factor 2 (FGF2) plays an important role in the development of osteoarthritis (OA) through the regulation of cartilage degradation. However, the molecular mechanism underlying FGF2-induced OA is poorly characterized. MicroRNAs (miRNAs) maintain cartilage homeostasis. To examine whether FGF2 regulates OA through the modulation of miRNA, we screened potential miRNA molecules that could be regulated through FGF2 using microarray analysis. The results showed that microRNA-105 (miR-105) was significantly downregulated in chondrocytes stimulated with FGF2. Runt-related transcription factor 2 (Runx2), a key transcription factor involved in OA, has been identified as a novel potential target of miR-105. FGF2 suppressed miR-105 expression through the recruitment of the subunit of the nuclear factor kappa B transcription complex p65 to the miR-105 promoter. The knockdown of Runx2 mimicked the effect of miR-105 and abolished the ability of miR-105 to regulate the expression of a disintegrin-like and metalloproteinase with thrombospondin 4 (ADAMTS4), ADAMTS5, ADAMTS7 and ADAMTS12, both of which are responsible for the degradation of collagen 2A1 (COL2A1) and aggrecan (ACAN). miR-105 is also required for FGF2/p65-induced Runx2 activation and ADAMTS expression. Moreover, miR-105 expression was downregulated in OA patients and inversely correlated with the expression of Runx2, ADAMTS7 and ADAMTS12, which were upregulated in OA patients. These data highlight that the FGF2/p65/miR-105/Runx2/ADAMTS axis might play an important role in OA pathogenesis and that miR-105 might be a potential diagnostic target and useful strategy for OA treatment.
Runx2 was identified as a novel direct target of miR-105. FGF2 inhibits miR-105 transcription through recruitment of p65 to miR-105 promoter. p65/miR-105 is essential for FGF2-mediated Runx2 and ADAMTS upregulation. miR-105 is downregulated in OA and inversely correlated with Runx2 expression.
成纤维细胞生长因子2(FGF2)通过调节软骨降解在骨关节炎(OA)的发展中起重要作用。然而,FGF2诱导OA的分子机制尚不清楚。微小RNA(miRNA)维持软骨稳态。为了研究FGF2是否通过调节miRNA来调控OA,我们使用微阵列分析筛选了可能受FGF2调控的潜在miRNA分子。结果显示,在FGF2刺激的软骨细胞中,微小RNA-105(miR-105)显著下调。已确定与OA相关的关键转录因子Runx2相关转录因子2(Runx2)是miR-105的一个新的潜在靶点。FGF2通过将核因子κB转录复合物p65的亚基募集到miR-105启动子来抑制miR-105的表达。敲低Runx2模拟了miR-105的作用,并消除了miR-105调节具有血小板反应蛋白4的解整合素样金属蛋白酶(ADAMTS4)、ADAMTS5、ADAMTS7和ADAMTS12表达的能力,这两种酶都负责胶原蛋白2A1(COL2A1)和聚集蛋白聚糖(ACAN)的降解。miR-105也是FGF2/p65诱导的Runx2激活和ADAMTS表达所必需的。此外,OA患者中miR-105表达下调,且与OA患者中上调的Runx2、ADAMTS7和ADAMTS12的表达呈负相关。这些数据表明,FGF2/p65/miR-105/Runx2/ADAMTS轴可能在OA发病机制中起重要作用,并且miR-105可能是OA治疗的潜在诊断靶点和有效策略。
Runx2被确定为miR-105的一个新的直接靶点。FGF2通过将p65募集到miR-105启动子来抑制miR-105转录。p65/miR-105对于FGF2介导的Runx2和ADAMTS上调至关重要。OA中miR-105下调且与Runx2表达呈负相关。